Gastrointestinal Stromal Tumor (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.GIST Oral Paciltaxel(Liporaxel)
Conditions: Gastrointestinal Stromal Tumors Interventions: Drug: Liporaxel Sponsors: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
GIST Oral Paclitaxel(Liporaxel)
Conditions: Gastrointestinal Stromal Tumors Interventions: Drug: Liporaxel Sponsors: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
Conditions: Advanced Gastrointestinal Stromal Tumor Interventions: Drug: Regorafenib (Stivarga, BAY73-4506) Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
Conditions: Gastrointestinal Stromal Tumors; GIST Interventions: Drug: Bezuclastinib in combination with sunitinib Sponsors: Sarcoma Alliance for Research through Collaboration; Cogent Biosciences, Inc.; Dana-Farber Cancer Institute; The Life Raft Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
Conditions: Gastrointestinal Stromal Tumors Interventions: Drug: Regorafenib Sponsors: M.D. Anderson Cancer Center; Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors Intervention: Sponsors: Fujian Medical University; Fujian Provincial Hospital; Fujian Cancer Hospital; First Affiliated Hospital of Fujian Medical University; 900 th Hospital of Joint Logistics Support Force; The First Affiliated Hospital of Xiamen University; The Second Affiliated Hospit al of Fujian Medical University; The First Hospital of Putian City; The Affiliated Hospital(Group) of Putian University; Zhangzhou Municipal Hospital of Fujian Province; Longyan City First Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2023 Category: Research Source Type: clinical trials
